| BSE: 524212 | Sector: Health care |
| NSE: WANBURY | ISIN Code: INE107F01022 |
| BSE 00:00 | 17 Aug | 25.50 |
0.70 (2.82%) |
OPEN
25.00 |
HIGH
26.00 |
LOW
25.00 |
| NSE 00:00 | 17 Aug | 25.00 |
0.90 (3.73%) |
OPEN
24.90 |
HIGH
25.30 |
LOW
23.50 |
| OPEN | 25.00 |
| PREVIOUS CLOSE | 24.80 |
| VOLUME | 3714 |
| 52-Week high | 55.00 |
| 52-Week low | 23.30 |
| P/E | |
| Mkt Cap.(Rs cr) | 60 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Wanbury Ltd is the fastest growing pharma company with a Compounded Annual Growth Rate(CAGR) of 68% over the last 6 years.The company has strong presence in domestic formulations,Active Pharmaceutical Ingredient(API) and Contract Research and manufacturing Services(CRAMS).The company also has its presence in Europe in formulations. Wanbury was incorporated as Pearl Distributors Pvt Ltd in 1990....> More
| Parameter | Values | ||
| Market Cap | ( cr) |
60 | |
| EPS - TTM | () |
[*S] | - |
| P/E Ratio | (X) | [*S] | - |
| Face Value | () |
10 | |
| Latest Dividend | (%) | 10.00 | |
| Latest Dividend Date | 29 Jul 2010 | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | -76.09 |
| P/B Ratio | () |
[*S] | -0.34 |
Standalone Un-Audited Financial Results Of The Company For The First Quarter Ended On 30Th June 2018
Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Financial Y
Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Financial Y
Board Meeting Intimation for Postponement Of The Board Meeting Dated Thursday 9Th August 2018
Notice Of Board Meeting For Approving The Audited Financial Results Of The Company For The First Qua
Particulars ( cr) |
Jun 2018 | Jun 2017 | % Chg |
| Net Sales | 85.78 | 93.78 | -8.53 |
| Other Income | 0.39 | 0.36 | 8.33 |
| Total Income | 86.17 | 94.15 | -8.48 |
| Total Expenses | 86.22 | 103.44 | -16.65 |
| Operating Profit | -0.04 | -9.29 | 99.57 |
| Net Profit | -8.52 | -20.06 | 57.53 |
| Equity Capital | 23.72 | 23.22 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Venus Remedies | 53.20 | 4.52 | 65.65 |
| Lactose (India) | 62.85 | -4.99 | 63.10 |
| Vivo Bio Tech | 63.10 | 5.87 | 62.15 |
| Wanbury | 25.50 | 2.82 | 60.49 |
| Guj. Themis Bio. | 37.65 | 0.94 | 54.67 |
| Gennex Lab. | 4.27 | 1.18 | 54.02 |
| Mercury Labs | 414.50 | 4.99 | 49.74 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -6.59% | -8.42% | 0.21% | 0.36% |
| 1 Month | 3.66% | 1.42% | 3.91% | 4.20% |
| 3 Month | -13.12% | -15.68% | 7.96% | 7.38% |
| 6 Month | -35.03% | -36.47% | 11.58% | 9.74% |
| 1 Year | -35.03% | -36.14% | 19.35% | 15.82% |
| 3 Year | -66.56% | -67.15% | 36.12% | 35.31% |
| Today's Low/High | 25.00 |
|
26.00 |
| Week Low/High | 23.95 |
|
27.00 |
| Month Low/High | 23.30 |
|
29.00 |
| YEAR Low/High | 23.30 |
|
55.00 |
| All TIME Low/High | 0.85 |
|
267.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
